Argobio
PrivateLast Round
VC Round
Mar 2, 2021
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Argobio is a French start-up studio dedicated to life sciences that creates and develops biotech companies from early-stage scientific innovations. It sources projects from European academic research institutions, focusing on therapeutic areas such as rare diseases, neurological disorders, oncology, and immunology. Argobio incubates these projects, providing scientific, entrepreneurial, and financial support to build them into standalone companies and advance them to a significant Series A financing round. The studio was launched in March 2021 with €50 million in capital from a syndicate of investors including Kurma Partners, Bpifrance, Angelini Pharma, Evotec, and the Institut Pasteur.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Argobio Comparables
Compare Argobio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remora Biotech | 83% | |
| AQYLA BioVentures | 83% | |
| Slingshot Therapeutics | 80% | |
Argobio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 2, 2021 |
Argobio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Angelini Ventures | VC Round |
| Institut Pasteur | VC Round |
| Bpifrance | VC Round |
| Kurma Partners | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Monthly visitors grew 381% MoM, from 420 to 2K.
- Jan 7, 2025
Launched a new RNA therapeutics company co-founded with the University of Southern Denmark.
Argobio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Argobio's valuation, stock price, and market status.